Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04303169
Title Substudy 02C: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Stage III Melanoma Who Are Candidates for Neoadjuvant Therapy (MK-3475-02C)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Merck Sharp & Dohme Corp.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | FRA

Facility Status City State Zip Country Details
The Angeles Clinic and Research Institute ( Site 3009) Recruiting Los Angeles California 90025 United States Details
Providence Saint John's Health Center ( Site 3010) Recruiting Santa Monica California 90404 United States Details
University of Colorado, Anschutz Cancer Pavilion ( Site 3012) Recruiting Aurora Colorado 80045 United States Details
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ( Site 3022) Recruiting Baltimore Maryland 21287 United States Details
NYU Clinical Cancer Center ( Site 3002) Recruiting New York New York 10016 United States Details
Duke Cancer Institute ( Site 3005) Recruiting Durham North Carolina 27710 United States Details
Martha Morehouse Tower ( Site 3020) Recruiting Columbus Ohio 43221 United States Details
Oregon Health & Science University ( Site 3013) Completed Portland Oregon 97239 United States Details
University of Pennsylvania Abramson Cancer Center ( Site 3008) Completed Philadelphia Pennsylvania 19104 United States Details
West Cancer Center - East Campus ( Site 3014) Recruiting Germantown Tennessee 38138 United States Details
Inova Schar Cancer Institute ( Site 3011) Recruiting Fairfax Virginia 22031 United States Details
Melanoma Institute Australia ( Site 3402) Recruiting Wollstonecraft New South Wales 2065 Australia Details
Tasman Oncology Research Pty Ltd ( Site 3403) Recruiting Southport Queensland 4215 Australia Details
Fiona Stanley Hospital ( Site 3401) Recruiting Murdoch Western Australia 6150 Australia Details
Hopital La Timone ( Site 3103) Recruiting Marseille Bouches-du-Rhone 13005 France Details
Institut Claudius Regaud ( Site 3105) Recruiting Toulouse cedex 9 Haute-Garonne 31059 France Details
Gustave Roussy ( Site 3101) Recruiting Villejuif Ile-de-France 94800 France Details
Centre Hospitalier Lyon Sud ( Site 3102) Recruiting Pierre Benite Rhone 69495 France Details
A.P.H. Paris, Hopital Saint Louis ( Site 3107) Recruiting Paris 75010 France Details
HaEmek Medical Center ( Site 3703) Recruiting Afula 1834111 Israel Details
Rambam Health Care Campus-Oncology ( Site 3704) Recruiting Haifa 3109601 Israel Details
Hadassah Ein Karem Jerusalem ( Site 3702) Recruiting Jerusalem 9112001 Israel Details
Rabin Medical Center-Oncology ( Site 3705) Recruiting Petah-Tikva 4941492 Israel Details
Chaim Sheba Medical Center ( Site 3701) Recruiting Ramat Gan 5265601 Israel Details
Istituto Europeo di Oncologia ( Site 3301) Recruiting Milano 20141 Italy Details
Policlinico Le Scotte - A.O. Senese ( Site 3377) Recruiting Siena 53100 Italy Details
Hôpitaux Universitaires de Genève (HUG)-Oncology ( Site 3603) Recruiting Genève Geneve 1205 Switzerland Details
CHUV Centre Hospitalier Universitaire Vaudois ( Site 3602) Completed Lausanne Vaud 1011 Switzerland Details
Universitaetsspital Zuerich ( Site 3601) Recruiting Zuerich Flughafen Zurich 8058 Switzerland Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field